OPTI-FREE PUREMOIST OPTI-FREE PUREMOIST 10ozRecalls & reported problems
Alcon Laboratories, Inc. · Opti-Free Pure Moist Multi-Purpose Disinfecting Solution 10 oz. · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00300650361040), received between Aug 25, 2023 and Nov 3, 2023 — classified as 2 injuries.
The most frequently reported specific device problem is “Device Emits Odor” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Device Emits Odor2
Patient problems
- Eye Pain2
- Foreign Body Sensation in Eye2
- Fungal Infection2
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
- Blurred Vision1
- Conjunctivitis1
- Dry Eye(s)1
- Excessive Tear Production1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryNov 3, 2023Device Emits Odor; Device Emits Odor
ON 30/NOV/2023, ADDITIONAL INFORMATION HAS BEEN RECEIVED STATES THAT CONSUMER WAS TREATED WITH MOXIFLOXACIN 0.5%, 3ML OPHTHALMIC SOLUTION AND PREDNISONE 1% 15ML OPHTHALMIC SUSPENSION EYE DROPS FOR THE EYE INFECTION. ADDITIONALLY, THE CONSUMER WAS TREATED WITH PREDNISONE 20MG TABLETS, KETOCONAZOLE 2% SHAMPOO 120ML, CIPROFLOXACIN 500MG TABLET, AND TRIAMCINOLONE 0.1% OINTMENT 80GM FOR SINUS AND SKIN RASHES. THE CURRENT CONDITION OF CONSUMER'S EYE IS SYMPTOMS RESOLVED, WITH THE AVAILABLE INFORMATION THE CASE STILL RETAIN AS SERIOUS AND REPORTABLE.
Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; Conjunctivitis; Eye Pain; Foreign Body Sensation in Eye; Fungal Infection; Headache; Hemorrhage/Blood Loss/Bleeding; Rash
MAUDE report 18065296 ↗InjuryAug 25, 2023Device Emits Odor; Device Emits Odor
INITIALLY RECEIVED FROM CONSUMER STATING THAT THE CONSUMER EXPERIENCED PUS, DRY EYE, BURNING, BLURRY VISION, SOLUTION SMELLED DIFFERENT, IRRITATION, TEARING, REDEYES AND EYE PAIN. FUNGAL INFECTION WAS THE DIAGNOSIS AND EYE DROPS WERE TAKEN. CURRENT PATIENT'S CONDITION IS SYMPTOMS CONTINUING. ADDITIONAL INFO HAS BEEN REQUESTED.
Patient problems: Blurred Vision; Dry Eye(s); Excessive Tear Production; Eye Burn; Eye Pain; Foreign Body Sensation in Eye; Fungal Infection; Purulent Discharge; Red Eye(s)
MAUDE report 17624608 ↗
Other Accessories, soft lens products devices
- OPTI-FREE REPLENISH OPTI-FREE REPLENISH 10ozAlcon Laboratories, Inc. · Accessories, soft lens products1 recall1 report
- Clear Care Clear Care 12ozAlcon Laboratories, Inc. · Accessories, soft lens products1 recall0 reports
- OPTI-FREE REPLENISH OPTI-FREE REPLENISH 2ozAlcon Laboratories, Inc. · Accessories, soft lens products1 recall0 reports
- OPTI-FREE REPLENISH OPTI-FREE REPLENISH 4ozAlcon Laboratories, Inc. · Accessories, soft lens products1 recall0 reports
- REFRESH CONTACTS® Contact Lens Comfort Drops 91822USAllergan, Inc. · Accessories, Soft Lens Products1 recall0 reports
- Clear Care Clear Care 2x12ozAlcon Laboratories, Inc. · Accessories, soft lens products4 reports
- Clear Care Clear Care 2x12ozAlcon Laboratories, Inc. · Accessories, soft lens products4 reports
- COMPLETE 93504LCAHZJohnson & Johnson Surgical Vision, Inc. · Accessories, soft lens products4 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page